Trial Profile
Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Crisaborole (Primary)
- Indications Circumscribed scleroderma
- Focus Proof of concept; Therapeutic Use
- 13 Aug 2020 Status changed from recruiting to completed.
- 22 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Jun 2020.
- 22 Jan 2020 Planned primary completion date changed from 1 Dec 2019 to 15 May 2020.